[Chart: Company Logo]
Chengdu Huasun Technology Group Inc., Ltd.
(Room 101, Floor 1, Building 2, No. 1168 Shuxin Avenue, High-tech Zone (West), Chengdu)
Securities Abbreviation: Huasun Technology
Securities Code: 000790
Prospectus for the Issuance of A-Shares to Specific Targets
(Registration Draft)
Sponsor (Lead Underwriter): Guotai Haitong Securities Co., Ltd.
(No. 618 Shangcheng Road, China (Shanghai) Pilot Free Trade Zone)
July 2026
Statement
-
The Company and all directors, members of the Audit Committee of the Board of Directors, and senior management warrant that this prospectus and other information disclosure materials do not contain any false records, misleading statements, or material omissions, and assume corresponding legal liability for their authenticity, accuracy, and completeness.
-
The person in charge of the Company, the person in charge of accounting work, and the person in charge of the accounting department guarantee the authenticity and completeness of the financial and accounting information in this prospectus.
-
This prospectus is prepared in accordance with the "Administrative Measures for the Registration of Securities Issuance by Listed Companies" and the "Contents and Format Standards for Information Disclosure by Companies Offering Securities to the Public No. 61 — Prospectus and Issuance Report for Securities Issued by Listed Companies to Specific Targets."
-
Any decision or opinion made by the China Securities Regulatory Commission, the Shenzhen Stock Exchange, or other government departments regarding this issuance does not imply their guarantee of the authenticity, accuracy, or completeness of the application documents and disclosed information, nor does it constitute a substantive judgment or guarantee of the issuer's profitability, investment value, or investor returns. Any statement to the contrary is a false representation.
-
According to the "Securities Law," after the securities are issued in accordance with the law, the issuer is responsible for changes in its operations and earnings. Investors shall independently judge the investment value of the issuer, make their own investment decisions, and bear the investment risks caused by changes in the issuer's operations and earnings or fluctuations in securities prices after the issuance.
Important Matters Notice
The Company specifically reminds investors to carefully read the full text of this prospectus before making investment decisions, and to pay special attention to the following matters.
I. Details of the Issuance
(1) The relevant matters for this issuance of A-shares to specific targets have been reviewed and approved by the 28th meeting of the 13th Board of Directors, the 2nd Extraordinary General Meeting of 2026, and the 31st meeting of the 13th Board of Directors, and have been approved by the Shenzhen Stock Exchange. It is still subject to the registration decision of the China Securities Regulatory Commission before implementation. The aforementioned approvals or registration are prerequisites for this issuance, and there is uncertainty regarding whether such approvals or registration can be obtained and the final timing thereof. Investors are advised to be aware of investment risks.
(2) The target of this issuance is the Company's indirect controlling shareholder, Yuanhong Bio. The target will subscribe for the shares in cash in RMB, with a proposed subscription amount of not less than 300 million RMB and not more than 350 million RMB. Yuanhong Bio has signed a conditional share subscription agreement and a supplementary agreement with the Company.
(3) This issuance constitutes a related-party transaction. When the Board of Directors reviewed the relevant matters, related directors abstained from voting, and this issuance was reviewed and approved by the independent directors' special meeting. When the General Meeting of Shareholders reviewed the matters, related shareholders abstained from voting on the relevant proposals.